Viridian Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Host Investor Conference Call on March 10, 2022
WALTHAM, Mass., March 03, 2022 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology…
Month: March 2022
Histogen to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Business Update
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics…
DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates
Montrouge, France, March 3, 2022 DBV Technologies Reports Full Year 2021 Financial Results and Recent…
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2021
– Approximately $113 Million of U.S. Product Sales in 2021 – – Approximately $13 Million…
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
-Top-line data readout from TERN-201 (VAP-1 inhibitor) clinical trial in NASH expected in March 2022…
Satsuma Pharmaceuticals Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2022 Annual Meeting
SOUTH SAN FRANCISCO, Calif., March 03, 2022 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA),…
IO Biotech Announces Appointment of David V. Smith to its Board of Directors
NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
Rain Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Progress
– Quarter-end cash position of $140.2 million provides runway to complete all ongoing and planned…
NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Multiple data readouts expected in 2022, including updates for all three clinical programs Ends 2021…
Longboard Pharmaceuticals Provides Corporate Update and Reports Full Year 2021 Financial Results
Initiated the Phase 1b/2a PACIFIC Study, evaluating LP352 in participants with developmental and epileptic encephalopathies…
Radius to Host Neuroscience R&D Webcast April 5, 2022
Focus: RAD011, our investigational synthetic cannabidiol oral solution Broad market interest in the underlying science,…
Unifi Protocol’s uTrade V2 Launches on TRON, Opening the Door to New Innovations in DeFi Trading
Singapore, Singapore–(Newsfile Corp. – March 3, 2022) – Unifi Protocol’s upgraded trading platform, uTrade V2,…
Tanzanite Silicon Solutions Demonstrates Industry’s First CXL Based Memory Expansion and Memory Pooling Products, Ushering in the Era of Next Generation Composable Data Centers
MILPITAS, Calif.–(BUSINESS WIRE)–Tanzanite Silicon Solutions Inc., the leader in the development of Compute Express LinkTM…
Vontier Joins MIT-led Global Alliance on Innovation to Combat Climate Change
RALEIGH, N.C.–(BUSINESS WIRE)–Vontier Corporation (“Vontier”) (NYSE: VNT) today announced that Vontier has joined the MIT…
Illinois Residents Sue Peoples Gas, Subsidiary of WEC, for Contaminating East Central Illinois’ Major Source of Water, According to FeganScott Law Firm
Suit alleges drinking water is hazardous due to leaks from Peoples Gas’ storage beneath aquifer…
MULTIMEDIA UPDATE — Preferabli Expands Personalization and Recommendation Platform To Encompass Wine, Beer & Spirits
Leading AI-Driven Software Company: Preferabli, formerly known as Wine Ring, Evolves Capabilities to Include Beer…
Crypto Fight Club Wins PancakeSwap LP Auction for the 2nd Time
Tallinn, Estonia–(Newsfile Corp. – March 3, 2022) – Crypto Fight Club dominates the PancakeSwap LP…
NetApp to Participate in Upcoming Technology Conference
SAN JOSE, Calif.–(BUSINESS WIRE)–NetApp (NASDAQ: NTAP), a global cloud-led, data centric software company, today announced…
CURE Pharmaceutical and Milagro Pharmaceuticals Collaborate for Registration and Approval to Sell Sildenafil Oral Thin Film in Mexico
COFEPRIS (Mexico’s equivalent of the US FDA) grants authorization for the manufacture, distribution and sale…
NYMOX Announces Submission of New Drug Application (NDA) to the FDA for Fexapotide Triflutate
IRVINE, Calif., March 03, 2022 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”)…